Wortley Pascale M, Schwartz Benjamin, Levy Paul S, Quick Linda M, Evans Brian, Burke Brian
National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Am J Prev Med. 2006 Mar;30(3):258-65. doi: 10.1016/j.amepre.2005.10.005.
The goal of the National Smallpox Vaccination Program was to vaccinate a cadre of healthcare workers and first responders who could care for smallpox patients in the event of an attack.
Using a convenience sample of health departments (n=49) and hospitals (n=60) in five states, we conducted a telephone interview between July 2003 and April 2004 of healthcare workers and first responders who chose not to receive smallpox vaccination. (Data were analyzed in 2004 and 2005.)
The response rate was 63%. Of 1895 respondents, 723 (38.2%) reported having a contraindication, 280 (14.8%) reported being contraindicated because of a household member's condition, and 892 (47.0%) reported having no contraindication to smallpox vaccination. Among respondents with no contraindication, the leading reasons for nonvaccination were concerns about side effects (20.6%) and not feeling that the risk of outbreak was high enough (19.5%). More than half (54.8%) were somewhat or very concerned about having an adverse reaction to the vaccine; Hispanics, blacks, and Asians were significantly more likely than whites to be somewhat or very concerned about side effects. Less than one fifth (17.9%) reported that there was a policy to financially compensate employees who developed side effects from vaccination, and 40.7% reported that there was a policy to provide liability coverage to employees who transmitted vaccinia to a patient.
Many people who chose not to receive smallpox vaccine perceived their personal risk-benefit balance as not favoring vaccination. The success of future smallpox vaccination efforts or vaccination against other bioterrorist health threats depends on addressing potential barriers to participation including compensation and liability issues, in addition to clearly communicating risks and benefits.
国家天花疫苗接种计划的目标是为一批医护人员和急救人员接种疫苗,以便在发生天花袭击事件时能够照料天花患者。
我们在五个州选取了卫生部门(n = 49)和医院(n = 60)作为便利样本,于2003年7月至2004年4月对选择不接种天花疫苗的医护人员和急救人员进行了电话访谈。(数据于2004年和2005年进行分析。)
回复率为63%。在1895名受访者中,723人(38.2%)报告有接种禁忌证,280人(14.8%)报告因家庭成员的状况而有禁忌证,892人(47.0%)报告无天花疫苗接种禁忌证。在无禁忌证的受访者中,不接种疫苗的主要原因是担心副作用(20.6%)以及认为疫情爆发风险不够高(19.5%)。超过一半(54.8%)的人对疫苗产生不良反应有些担心或非常担心;西班牙裔、黑人和亚裔比白人更有可能对副作用有些担心或非常担心。不到五分之一(17.9%)的人报告有政策对因接种疫苗出现副作用的员工给予经济补偿,40.7%的人报告有政策为将牛痘传染给患者的员工提供责任保险。
许多选择不接种天花疫苗的人认为他们个人的风险 - 收益平衡不支持接种。未来天花疫苗接种工作或针对其他生物恐怖主义健康威胁的疫苗接种的成功,除了要清晰地传达风险和收益外,还取决于解决包括补偿和责任问题在内的参与潜在障碍。